Journal Article Summary

The article discusses a rare side effect associated with intravenous zoledronic acid (ZA), a medication commonly used to treat osteoporosis, particularly in patients who cannot tolerate oral bisphosphonates. While ZA is known for causing flu-like symptoms, this case highlights the occurrence of acute iridocyclitis, an inflammatory condition affecting the eye, following the administration of the drug. Understanding such side effects is crucial for healthcare providers to ensure patient safety and to manage any complications that may arise from treatment.

The study presents a case involving a 71-year-old woman diagnosed with osteoporosis who experienced severe eye symptoms after receiving ZA. Five days post-infusion, she reported issues such as eye redness, tearing, and blurry vision, which led to multiple emergency department visits. Upon examination, she was diagnosed with acute iridocyclitis and treated with eye drops, resulting in significant symptom improvement within a few weeks. This case emphasizes the need for awareness of potential ocular inflammation as a rare but serious reaction to ZA.

Limitations of the study include its focus on a single case, which may not represent the broader population of patients receiving ZA. Patients should be aware of the possibility of ocular side effects and discuss any unusual symptoms with their healthcare providers promptly. Additionally, optimizing vitamin D levels before treatment may help mitigate some risks, although this particular patient had adequate vitamin D at the time of her infusion. Overall, early recognition and treatment of such side effects are essential for ensuring patient safety.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Ankireddypalli Anvitha Reddy, Sibley Shalamar Dionne. THU443 Acute Iridocyclitis Associated With Intravenous Zoledronic Acid. Journal of the Endocrine Society 2023. DOI: 10.1210/jendso/bvad114.404. PMCID: PMC10555134.

Featured Pill Pals Product

Pill PalsĀ® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your medsā„¢. As a Pharmacy Benefits Management organization, Pill PalsĀ® gives patients the best cash prices on all meds. Pill PalsĀ® is part of The Health PalsĀ® Company (Health PalsĀ®, Med PalsĀ®, Skin PalsĀ® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]